Why Is HEARTFLOW INC (HTFL) Stock Up Today?

Heartflow Inc. (HTFL) surged by 5.44% to $44.22 in Friday's session, driven by a recent price target upgrade from Morgan Stanley and a string of positive analyst commentary. The stock has gained 54.9% over the last eight trading sessions and is currently within 0.2% of its 52-week high. The move reflects a broader market response to the company's strong revenue performance and upgraded guidance, which has improved its growth outlook.

What Happened

Heartflow's stock opened at $41.60, slightly below the prior close of $41.94, and climbed steadily throughout the session. By 11:50 AM ET, the stock reached a high of $44.23, with volume reaching 1.0 million shares, or 0.8 times the 3-month average. The rally was catalyzed by Morgan Stanley raising its price target for HTFL to $40 from $35. Additional support came from Canaccord Genuity and Piper Sandler, both of which increased their price targets to $45. Benzinga reported that the stock's strong Q2 results and upgraded guidance also contributed to the upward momentum.

What The Data Shows

Heartflow has a market capitalization of $2.3 billion and remains unprofitable, with a trailing twelve-month (TTM) earnings per share (EPS) of -1.97. Despite this, the company's revenue has grown by 40.6% TTM, and its stock has shown strong momentum, having moved from $27.17 to $42.08 in eight sessions. On August 18, the stock printed 25 fresh 52-week highs and two fresh 52-week lows. Insider activity has been mixed, with five sell transactions totaling $3.5 million reported in the last 90 days, including recent sales by CEO John Farquhar and Chief Medical Officer Campbell Rogers.

What To Watch

Heartflow does not have an upcoming earnings report scheduled, but continued analyst coverage and price target adjustments will be key to monitoring the stock's trajectory. Investors should also watch for shifts in insider activity and broader market sentiment toward the healthcare sector.